This is a pleasant surprise to me. Surprised that I did not see this included in the 2017 business outlook, but it's possible that I may have missed it because I tend to speed read everything?:
ADXS-HER2
Initiate a study in pediatric osteosarcoma in collaboration with the Children’s Oncology Group in 2017.